Analysis of Characteristics of Drug Resistant TB (DR) Patients, Using The Liquid Mycobacteria Growth Indicator Tube (MGITta) Method Based on Drug Consumption Compliance
Analisis Karakteristik Pasien TB Resisten Obat (RO) Menggunakan Metode Cair Mycobacteria Growth Indicator Tube (MGIT) Berdasarkan Kepatuhan Konsumsi Obat
DOI:
https://doi.org/10.21070/ups.5731Keywords:
- Tuberculosis (TB), adherence, medication consumption, conversion.Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. One of the factors for the success of TB treatment is patient adherence to medication. Patient adherence to medication can be observed from the conversion results in laboratory examinations. The aim of the study is to determine the relationship between the characteristics of Drug-Resistant TB patients and medication adherence. The design used in this study is Descriptive Exploratory. The study was conducted from March to May 2024 at the Microbiology Laboratory Unit of RSUD dr. Saiful Anwar Malang. The samples used were 50 Drug-Resistant TB sputum samples with the inclusion criteria of purulent sputum, collected first thing in the morning, volume >1 ml, resistant to second-line TB drugs. Samples were examined using the BACTEC (MGIT) 960 culture tool.. The Chi-Square test showed no significant relationship between gender and age of Drug-Resistant TB patients with medication adherence (p=0.134, p=0.563).
Downloads
References
Pathrikar, Bansal, and mulay, “Comparison of Ziehl-Neelsen Smear Microscopy and AFB Culture in a Resource Limited Setting from Various Clinical Samples,” Internasional Journal of Health Science and Research, vol. 10, no. 4, pp. 46–51, 2020.
N. Sharif et al., “Comparison of different diagnostic modalities for isolation of Mycobacterium Tuberculosis among suspected tuberculous lymphadenitis patients | Comparação de diferentes modalidades de diagnóstico para isolamento de Mycobacterium tuberculosis entre paciente,” Brazilian Journal of Biology, vol. 83, pp. 1–9, 2023.
N. N. Linh et al., “World Health Organization treatment outcome definitions for tuberculosis: 2021 update,” European Respiratory Journal, vol. 58, no. 2, 2021, doi: 10.1183/13993003.00804-2021.
P. Kemenkes, Temukan TB Obati Sampai Sembuh Penatalaksanaan Tuberkulosis Resisten Obat di Indonesia. Jakarta: Kementerian Kesehatan RI, 2020.
S. Robert, A. Uppe, S. Sawant, D. Gupta, and G. Nair, “Comparison Study of GENEXPERT versus TB MGIT Culture in Extra Pulmonary Tuberculosis,” American Journal of Infectious Diseases and Microbiology, vol. 8, no. 1, pp. 1–13, 2020, doi: 10.12691/ajidm-8-1-1.
A. Rukmana, Petunjuk Teknis Dan Pemantapan Mutu Pemeriksaan Biakan, Identifikasi, dan Uji Kepekaan Mycobacterium tuberculosis complex Terhadap Obat Anti Tuberkulosis Pada Media Padat dan Media Cair. Jakarta: Kementerian kesehatan RI, 2022.
T. O. Aremu, O. E. Oluwole, K. O. Adeyinka, and J. C. Schommer, “Medication Adherence and Compliance: Recipe for Improving Patient Outcomes,” Pharmacy, vol. 10, no. 5, p. 106, 2022, doi: 10.3390/pharmacy10050106.
L. Du et al., “Determinants of medication adherence for pulmonary tuberculosis patients during continuation phase in Dalian, Northeast China,” Patient Prefer Adherence, vol. 14, pp. 1119–1128, 2020, doi: 10.2147/PPA.S243734.
M. I. Bakhtiar, C. Wiedyaningsih, N. M. Yasin, and S. A. Kristina, “Hubungan Karakteristik, Kepatuhan, dan Outcome Klinis Pasien Tuberkulosis Paru Di Puskesmas Kabupaten Bantul,” Majalah Farmaseutik, vol. 17, no. 2, pp. 256–269, 2021, doi: 10.22146/farmaseutik.v17i2.60681.
N. Nuratiqa, R. Risnah, M. A. Hafid, A. Paharani, and M. Irwan, “Faktor Yang Berhubungan Dengan Kepatuhan Minum Obat Anti Hipertensi,” BIMIKI (Berkala Ilmiah Mahasiswa Ilmu Keperawatan Indonesia), vol. 8, no. 1, pp. 16–24, 2020, doi: 10.53345/bimiki.v8i1.122.
Downloads
Additional Files
Posted
License
Copyright (c) 2024 UMSIDA Preprints Server
This work is licensed under a Creative Commons Attribution 4.0 International License.
